{"id":"https://openalex.org/W1963759496","doi":"https://doi.org/10.1159/000139117","title":"Dizocilpine (MK-801) Blocks Tolerance to the Analgesic but Not to the Hyperthermic Effect of Morphine in the Rat","display_name":"Dizocilpine (MK-801) Blocks Tolerance to the Analgesic but Not to the Hyperthermic Effect of Morphine in the Rat","alternate_titles":[],"publication_year":2008,"publication_date":"2008-06-10","ids":{"openalex":"https://openalex.org/W1963759496","doi":"https://doi.org/10.1159/000139117","mag":"1963759496","pmid":"https://pubmed.ncbi.nlm.nih.gov/8278457"},"language":"en","primary_location":{"id":"doi:10.1159/000139117","doi":"https://doi.org/10.1159/000139117","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000139117","pdf_url":null,"source":{"id":"https://openalex.org/S106137443","display_name":"Pharmacology","issn_l":"0031-7012","issn":["0031-7012","1423-0313"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1963759496"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109262897","display_name":"Hemendra N. Bhargava","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I39422238","display_name":"University of Illinois Chicago","ror":"https://ror.org/02mpq6x41","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hemendra N. Bhargava","raw_affiliation_strings":["Department of Pharmacodynamics, University of Illinois at Chicago 60612","Department of Pharmacodynamics (M/C 865), University of Illinois at Chicago, Health Sciences Center, Chicago, Ill., USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacodynamics, University of Illinois at Chicago 60612","institution_ids":["https://openalex.org/I39422238"]},{"raw_affiliation_string":"Department of Pharmacodynamics (M/C 865), University of Illinois at Chicago, Health Sciences Center, Chicago, Ill., USA","institution_ids":["https://openalex.org/I39422238"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071322894","display_name":"George A. Matwyshyn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I39422238","display_name":"University of Illinois Chicago","ror":"https://ror.org/02mpq6x41","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"George A. Matwyshyn","raw_affiliation_strings":["Department of Pharmacodynamics (M/C 865), University of Illinois at Chicago, Health Sciences Center, Chicago, Ill., USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacodynamics (M/C 865), University of Illinois at Chicago, Health Sciences Center, Chicago, Ill., USA","institution_ids":["https://openalex.org/I39422238"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I39422238"],"apc_list":null,"apc_paid":null,"fwci":0.3959,"has_fulltext":false,"cited_by_count":59,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.61103602,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":92},"biblio":{"volume":"47","issue":"6","first_page":"344","last_page":"350"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.415800005197525,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.415800005197525,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":0.16760000586509705,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.13420000672340393,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mk-801","display_name":"MK-801","score":0.9990000128746033},{"id":"https://openalex.org/keywords/morphine-tolerance","display_name":"morphine tolerance","score":0.7720000147819519},{"id":"https://openalex.org/keywords/nmda-receptor-antagonist","display_name":"NMDA receptor antagonists","score":0.847000002861023},{"id":"https://openalex.org/keywords/analgesic-tolerance","display_name":"analgesic tolerance","score":0.8270000219345093},{"id":"https://openalex.org/keywords/opioid-analgesia","display_name":"opioid analgesia","score":0.7549999952316284},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.41100001335144043},{"id":"https://openalex.org/keywords/dose-dependent-effects","display_name":"dose-dependent effects","score":0.492000013589859},{"id":"https://openalex.org/keywords/mortality","display_name":"mortality","score":0.3529999852180481}],"concepts":[{"id":"https://openalex.org/C2777389121","wikidata":"https://www.wikidata.org/wiki/Q81225","display_name":"Morphine","level":2,"score":0.8958746194839478},{"id":"https://openalex.org/C2777836312","wikidata":"https://www.wikidata.org/wiki/Q4386371","display_name":"Dizocilpine","level":4,"score":0.890271782875061},{"id":"https://openalex.org/C2780820201","wikidata":"https://www.wikidata.org/wiki/Q173235","display_name":"Analgesic","level":2,"score":0.8148726224899292},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.6639596223831177},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.624270498752594},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.618243932723999},{"id":"https://openalex.org/C2779985140","wikidata":"https://www.wikidata.org/wiki/Q1425425","display_name":"Drug tolerance","level":2,"score":0.5937275290489197},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.42423146963119507},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3995404839515686},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2633240222930908},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25323525071144104}],"mesh":[{"descriptor_ui":"D000698","descriptor_name":"Analgesia","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004361","descriptor_name":"Drug Tolerance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005334","descriptor_name":"Fever","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009020","descriptor_name":"Morphine","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D009020","descriptor_name":"Morphine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016291","descriptor_name":"Dizocilpine Maleate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016291","descriptor_name":"Dizocilpine Maleate","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1159/000139117","doi":"https://doi.org/10.1159/000139117","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000139117","pdf_url":null,"source":{"id":"https://openalex.org/S106137443","display_name":"Pharmacology","issn_l":"0031-7012","issn":["0031-7012","1423-0313"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology","raw_type":"journal-article"},{"id":"pmid:8278457","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8278457","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9476000070571899,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2654367679","display_name":"OPIOID ACTIONS AND NEUROPEPTIDES","funder_award_id":"K02DA000130","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G747696871","display_name":"HYPOTHALAMUS &NARCOTIC EFFECTS","funder_award_id":"R01DA002598","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2047957323","https://openalex.org/W1990180318","https://openalex.org/W1980565037","https://openalex.org/W2084124116","https://openalex.org/W2110945744","https://openalex.org/W2077361228","https://openalex.org/W1970267626","https://openalex.org/W2041608646","https://openalex.org/W1990776459","https://openalex.org/W2001131419"],"abstract_inverted_index":{"The":[0,74],"effect":[1,99,124,151,183],"of":[2,12,20,48,51,76,94,100,119,125,129,152,157,163,184],"dizocilpine":[3],"(MK-801),":[4],"an":[5],"N-methyl-D-aspartate":[6],"receptor":[7],"antagonist,":[8],"on":[9],"the":[10,15,25,57,66,85,92,97,109,122,146,149,160,178,181,187],"development":[11,93],"tolerance":[13,95,120,147,179],"to":[14,28,96,121,144,148,180],"analgesic":[16,98,123,182],"and":[17,64,81],"hyperthermic":[18,150],"effects":[19],"morphine":[21,29,40,185],"was":[22,34,59,69,104],"determined":[23],"in":[24,30,65,166,176,186],"rat.":[26,188],"Tolerance":[27],"male":[31],"Sprague-Dawley":[32],"rats":[33],"induced":[35],"by":[36],"implanting":[37],"subcutaneously":[38],"6":[39],"pellets":[41],"during":[42],"a":[43,62,72,88,112,116,137,141],"7-day":[44],"period.":[45],"Two":[46],"schedules":[47,156],"intraperitoneal":[49],"injections":[50],"MK-801":[52,77,90,114,130,134,158,164,173],"were":[53,78],"used.":[54],"In":[55,84,108,154],"one,":[56],"drug":[58],"injected":[60,70],"once":[61,87,136],"day,":[63,89,113],"other":[67],"it":[68],"twice":[71,111,140],"day.":[73],"doses":[75,128],"0.03,":[79],"0.1":[80],"0.3":[82],"mg/kg.":[83],"treatment":[86,110],"blocked":[91],"morphine,":[101],"but":[102],"there":[103],"no":[105],"dose-dependent":[106,117],"effect.":[107],"produced":[115,131],"inhibition":[118],"morphine.":[126,153],"Higher":[127],"high":[132,167],"mortality.":[133,168],"given":[135],"day":[138,142],"or":[139],"failed":[143],"affect":[145],"both":[155],"treatment,":[159],"highest":[161],"dose":[162],"resulted":[165],"It":[169],"is":[170,174],"concluded":[171],"that":[172],"selective":[175],"blocking":[177]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1963759496","counts_by_year":[{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}
